News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,832 Results
Type
Article (14846)
Company Profile (258)
Press Release (281728)
Section
Business (91128)
Career Advice (155)
Deals (16100)
Drug Delivery (28)
Drug Development (53340)
Employer Resources (31)
FDA (6763)
Job Trends (5509)
News (164143)
Policy (12293)
Tag
Academia (945)
Africa (192)
Allergies (31)
Alliances (25798)
Alzheimer's disease (724)
Antibody-drug conjugate (ADC) (31)
Approvals (6725)
Arizona (40)
Artificial intelligence (30)
Asia (29289)
Australia (4211)
Bankruptcy (102)
Best Places to Work (4571)
Biotechnology (218)
C2C Services and Suppliers (16096)
California (1227)
Canada (531)
Cancer (305)
Career advice (136)
CAR-T (33)
Cell therapy (94)
China (100)
Clinical research (41712)
Collaboration (87)
Colorado (35)
Compensation (39)
Connecticut (40)
COVID-19 (1055)
Cystic fibrosis (58)
Data (218)
Diabetes (39)
Diagnostics (1580)
Earnings (32679)
Employer resources (29)
Europe (42944)
Events (49557)
Executive appointments (98)
FDA (6881)
Florida (122)
Funding (98)
Gene editing (28)
Gene therapy (78)
GLP-1 (278)
Government (1172)
Healthcare (7045)
Hotbed/Location (200369)
Illinois (77)
Indiana (43)
Infectious disease (1064)
Inflammatory bowel disease (81)
IPO (7950)
Job creations (1034)
Job search strategy (132)
Kansas (56)
Layoffs (180)
Legal (2111)
Liver cancer (31)
Lung cancer (73)
Maryland (193)
Massachusetts (1022)
Medical device (3426)
Medtech (3428)
Mergers & acquisitions (8150)
Metabolic disorders (133)
Michigan (37)
Minnesota (81)
Neuroscience (827)
New Jersey (342)
New York (394)
NextGen Class of 2024 (2095)
Non-profit (876)
North Carolina (332)
Northern California (538)
Obesity (76)
Ohio (62)
Opinion (86)
Parkinson's disease (30)
Patents (36)
Pennsylvania (276)
People (27209)
Pharmaceutical (41)
Phase I (14316)
Phase II (19208)
Phase III (12627)
Pipeline (79)
Postmarket research (981)
Preclinical (5988)
Press Release (32)
Rare diseases (103)
Real estate (1855)
Regulatory (9464)
Research institute (971)
South America (270)
Southern California (508)
Startups (2168)
Texas (115)
United States (4759)
Vaccines (135)
Washington State (153)
Weight loss (58)
Date
Today (64)
Last 7 days (429)
Last 30 days (1413)
Last 365 days (22924)
2024 (15950)
2023 (23964)
2022 (30247)
2021 (31139)
2020 (26589)
2019 (18343)
2018 (13444)
2017 (15639)
2016 (13740)
2015 (16812)
2014 (12452)
2013 (9312)
2012 (9526)
2011 (9706)
2010 (9313)
296,832 Results for "immunocellular therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SEED Therapeutics Appoints Eisai Co., Ltd.’s Dr. Yoshiharu Mizui to Board of Directors
September 12, 2024
·
2 min read
Pharm Country
EOM PHARMACEUTICAL HOLDINGS, INC. ANNOUNCES NAME CHANGE FROM IMMUNOCELLULAR THERAPEUTICS, LTD.
EOM Pharmaceutical Holdings, Inc. (“EOM”), a clinical-stage pharmaceutical company, today announced its name change from ImmunoCellular Therapeutics Ltd., to EOM Pharmaceutical Holdings, Inc.
November 10, 2022
·
3 min read
Business
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. announced the companies have completed an exclusive worldwide license agreement for the rights to MZE001, an investigational oral glycogen synthase 1 inhibitor that aims to address Pompe disease by limiting disease-causing glycogen buildup.
May 10, 2024
·
6 min read
Press Releases
Silexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business Combination
August 16, 2024
·
5 min read
Press Releases
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
September 12, 2024
·
4 min read
Press Releases
Aligos Therapeutics Announces Clinical Collaboration with Xiamen Amoytop Biotech Co., Ltd.
July 22, 2024
·
5 min read
Business
Mid-Atlantic BioTherapeutics, Inc. and SMITM Capital Markets Ltd enter into a significant financing agreement
SMITM CAPITAL MARKETS LTD, has announced a significant agreement with Mid-Atlantic BioTherapeutics, Inc. (MABT), a clinical-stage ready US biopharmaceutical company.
June 19, 2024
·
4 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
ImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ Technology
ImmunoPrecise Antibodies Ltd., a leader in AI-driven biotherapeutic research and technology, announces that its subsidiary, BioStrand, has been honored with the prestigious 2024 Impact Award, sponsored by InterSystems.
June 12, 2024
·
5 min read
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.
July 1, 2024
·
5 min read
1 of 29,684
Next
